- Report
- April 2026
- 111 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- January 2026
- 159 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2026
- 185 Pages
Global
From €2272EUR$2,500USD£1,953GBP
- Report
- August 2026
- 172 Pages
Global
From €3589EUR$3,950USD£3,085GBP
- Report
- August 2026
- 176 Pages
Global
From €3589EUR$3,950USD£3,085GBP
- Report
- August 2026
- 172 Pages
Global
From €3589EUR$3,950USD£3,085GBP
- Report
- August 2026
- 171 Pages
Global
From €3589EUR$3,950USD£3,085GBP
- Report
- May 2026
- 152 Pages
Global
From €3589EUR$3,950USD£3,085GBP
- Report
- February 2026
- 200 Pages
Global
From €4539EUR$4,995USD£3,902GBP
- Report
- April 2026
- 160 Pages
Global
From €3017EUR$3,320USD£2,593GBP
€3771EUR$4,150USD£3,242GBP
- Report
- January 2026
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- January 2026
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- April 2026
- 208 Pages
Global
From €3500EUR$4,126USD£3,114GBP
- Report
- October 2025
- 90 Pages
Global
From €4089EUR$4,500USD£3,515GBP
- Report
- July 2026
- 86 Pages
Middle East
From €4316EUR$4,750USD£3,710GBP
- Report
- July 2026
- 70 Pages
Europe
From €4316EUR$4,750USD£3,710GBP
- Report
- July 2026
- 82 Pages
Europe
From €4316EUR$4,750USD£3,710GBP
- Report
- May 2026
- 150 Pages
United States
From €2534EUR$2,789USD£2,178GBP
- Report
- August 2023
- 1500 Pages
Global
From €7951EUR$8,750USD£6,835GBP
- Report
- October 2022
- 348 Pages
Singapore, Malaysia, Indonesia Singapore, Malaysia, Indonesia
From €4543EUR$5,000USD£3,906GBP

The Molecular Assay market within the In Vitro Diagnostics (IVD) industry is a rapidly growing segment. It is composed of a variety of technologies and products used to detect and measure the presence of specific molecules in biological samples. These assays are used to diagnose and monitor diseases, detect genetic mutations, and identify infectious agents. Molecular assays are also used in research and drug development.
Molecular assays are typically performed in laboratories, but there is an increasing trend towards point-of-care testing. This allows for faster results and improved patient outcomes. Additionally, the development of new technologies such as next-generation sequencing and digital PCR are driving the growth of the molecular assay market.
Notable companies in the Molecular Assay market include Abbott, Becton Dickinson, Roche, Siemens Healthineers, Thermo Fisher Scientific, and Qiagen. Show Less Read more